ARCHIVES

Iressa Just As Effective As Chemotherapy For Second-Line Therapy, Study Finds

This article is from The Cancer Letter archive.

Vol. 31 No. 11 | November 28, 2008

Download PDF Visit The Full Archive

Related Articles

Grant Review: NIH Names Members To New Clinical Oncology Review Panel

February 26, 1999

First NCI Director To Resign Due To Presidential Election?

December 15, 2000

NAS Committee Urges Greater Rewards For Interdisciplinary Research.

January 21, 2005

In Brief: Francis Giles named deputy director of Lurie Cancer Center

October 17, 2014

NCI funds nine centers for $14.9 million integrative biology program.

October 29, 2004

Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer

June 5, 2009